New Delhi: Bharat Biotech on Wednesday said a study has demonstrated that a booster dose of Covaxin has a neutralising effect on the Omicron and Delta variants of COVID-19. A study conducted at Emory University demonstrated that subjects who received a booster dose of Covaxin (BBV152) six months after getting a primary two-dose series have witnessed neutralising of the SARS-CoV-2 Omicron and Delta variants, the vaccine major said in a statement. Earlier studies had demonstrated the neutralising potential of Covaxin against other SARS-CoV-2 variants – Alpha, Beta, Delta, Zeta and Kappa, it added. Read all the Latest News , Trending News , Cricket News , Bollywood News , India News and Entertainment News here. Follow us on Facebook, Twitter and Instagram.
Covaxin maker Bharat Biotech said that a study conducted at Emory University showed that subjects who received a booster shot six months after getting a primary two-dose series have witnessed neutralising of the Omicron and Delta variants
Advertisement
End of Article


)

)
)
)
)
)
)
)
)
